The business of biotech

Inside the discoveries, personalities, and deals driving drug development. Sign up for The Readout newsletter to get the latest on biotech delivered to your inbox https://www.statnews.com/signup/readout/

87 Viewers•409 Page flips•595 Followers•486 Stories

Most recent stories in The business of biotech

STAT
12 hours ago
Novartis is building a new radioligand plant in China
STAT - Meghana Keshavan
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hiya. Today, we explore …
STAT
18 hours ago
How sickle cell became the first disease treated by CRISPR
STAT - Jason Mast
Nearly a decade ago, consultants delivered to Rodger Novak a kind of Sears catalog of human malady: 200 pages, listing dozens of different diseases, …
STAT
3 days ago
Johnson & Johnson bets heavy on AI-driven drug discovery
STAT - Meghana Keshavan
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Today we talk about …
STAT
3 days ago
STAT Virtual Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D
STAT
Editor’s note: A recording of the event is embedded below. After a few go-go years, the early-stage biotech market has cooled considerably. Two VCs …
STAT
4 days ago
Do GLP-1s have a future treating alcoholism?
STAT - Damian Garde
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hello, everyone. Damian …
STAT
4 days ago
AbbVie buys Immunogen, maker of targeted cancer drugs, for $10 billion
STAT - Damian Garde
AbbVie will pay $10 billion for the biotech firm Immunogen, the company said Thursday, acquiring an approved treatment for ovarian cancer and buying …

See more stories

The business of biotech

Magazine

More Magazines by STAT

Storyboards by STAT